ClinicalTrials.Veeva

Menu

The Effect of Foot Reflexology After Cesarean Section

N

Nülüfer Erbil

Status

Unknown

Conditions

Postoperative Pain
Gastrointestinal Motility Disorder

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Standardized, quality and evidence-based nursing care after cesarean section is important to prevent or minimize complications that may occur after cesarean section. This evidence-based care will contribute to the shortening of the recovery period of the mother, the early start of postpartum bowel movements, the decrease in the perceived pain level, and the increase in postpartum comfort, thus facilitating the adaptation to new life and roles. On the other hand, although a limited number of studies reported the effects of reflexology, no study investigating the effect of reflexology on pain, comfort level and GIS motility developed after SD was found. In this study, it was aimed to determine the effect of foot reflexology on pain, intestinal motility and comfort after cesarean section.

Hypothesis(s):

H1: Foot reflexology after cesarean section reduces the level of pain perception.

H2: Foot reflexology after cesarean section increases intestinal motility. H3: Foot reflexology after cesarean section increases postpartum comfort.

Enrollment

70 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  • 18 and over,
  • Performing SD under general anesthesia,
  • Cesarean section at 37-42 weeks of gestation,
  • The only live SD made,
  • Written / verbal communication can be established,
  • At least primary school graduate,
  • Not having any problems during her pregnancy,
  • Women who agree to participate in the study will be taken into the sample. Exclusion Criteria
  • Being under 18 years old,
  • Those who gave birth by cesarean section before 37-42 weeks of gestation,
  • Having chronic constipation, diarrhea and using any laxative type medication,
  • Having problems such as fractures, dislocations, arthritis, phlebitis, wounds, burns, fungus, eczema, inflammation in the foot tissue,
  • Having cardiovascular system disease,

Trial contacts and locations

0

Loading...

Central trial contact

Mevlüde Alpaslan Arar; Nülüfer Erbil, Prof.Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems